Data / Form D filings / JAZZ PHARMACEUTICALS INC
JAZZ PHARMACEUTICALS INC: Form D filings
JAZZ PHARMACEUTICALS INC, a pharmaceuticals company in Palo Alto, CA, filed 4 Form D notices with the SEC in 2009. The latest, on November 27, 2009, reports an offering of $2 million with nothing sold yet to 1 investor.
Find out what JAZZ PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3180 PORTER DRIVE, Palo Alto, CA, 94304
- Phone
- (650) 496-3777
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1232524
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 27, 2009 | Amendment | $2,024,000 | $0 | $2,024,000 | 1 | May 7, 2008 | sec.gov |
| Nov 27, 2009 | Amendment | $87,338,700 | $80,000,000 | $7,338,700 | 12 | Jun 24, 2005 | sec.gov |
| Nov 25, 2009 | Amendment | $125,250,873 | $120,000,000 | $5,250,873 | 12 | Mar 14, 2008 | sec.gov |
| Jul 8, 2009 | New notice | $6,999,998 | $6,999,998 | $0 | 2 | Jul 7, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael W. Michelson | Director | |
| James B. Tananbaum | Director | |
| Carol A. Gamble | Executive Officer | |
| Nathaniel M. Zilkha | Director | |
| Patrick G. Enright | Director | |
| Bryan C. Cressey | Director | |
| Bruce C. Cozadd | Executive Officer, Director | |
| Alan M. Sebulsky | Director | |
| Kenneth W. O'Keefe | Director | |
| James C. Momtazee | Director | |
| Samuel D. Colella | Director | |
| Joan E. Colligan | Executive Officer | |
| Robert M. Myers | Executive Officer, Director | |
| Janne L.T. Wissel | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Nov 23, 2009 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what JAZZ PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.